The coliform mastitis causes severe losses on dairy farms. Traditional strategies based on prophylaxis and control programs are not sufficient in some cases. New tools have emerged in order to increase the immunity of animals with emphasis on vaccines for mastitis. The aim of this study was to determine the effects on milk quality, on the infectious status of cows and the use of systemic antimicrobial therapy after the use of a mastitis multivalent vaccine (STRARVAC®, HIPRA) in a farm with serious problems of coliform mastitis.
Impact of the use of a mastitis multivalent vaccine: a case study
Publications
Cattle
The results of the introduction of a multivalent vaccine for mastitis show a reduction of SCC in the bulk milk tank, a reduction in the number of new infections and chronic animal and a significant reduction of the antibiotic systemic therapy. The benefits obtained with the vaccination program justify their use and maintenance on the farm and must be considered on mastitis control programs.